#VisualAbstract: A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19 did not show any benefit
1. In this double-blind, randomized trial, hydroxychloroquine did not reduce symptom severity in an adult, outpatient population. 2. More side ...